Emily Perry-Hartlein, APRN
Family · Lady Lake, FLNPI 1841691987
Payments from drug & device makers
Across 95 payments — averaging $39.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Astellas Pharma US Inc$434
- Dentsply IH AB$305
- Rochester Medical Corporation$279
- Pfizer$277
- Bayer$144
- plus $907 from 19 others
What the payments were for
- Speaking & faculty fees$1,36537%
- Food & beverage$1,77248%
- Education$48813%
- Gifts$882%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $1,365 |
| Astellas Pharma US Inc | 12 | $434 |
| Dentsply IH AB | 17 | $305 |
| Rochester Medical Corporation | 12 | $279 |
| Pfizer | 9 | $277 |
| Bayer | 7 | $144 |
| Myovant Sciences Inc. | 8 | $131 |
| Urovant Sciences Inc | 3 | $131 |
| Incyte Corporation | 2 | $101 |
| AbbVie(2 entities) | 4 | $84 |
| Dendreon Pharmaceuticals LLC | 2 | $60 |
| Teleflex LLC | 2 | $54 |
| BD | 1 | $42 |
| Coloplast | 2 | $42 |
| Merck | 2 | $38 |
| AstraZeneca | 1 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Urogen Pharma, Inc. | 1 | $32 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $26 |
| Blue Earth Diagnostics | 1 | $21 |
| Accord Healthcare, Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Laborie Medical Technologies Corp. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,713 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 65 | $49,666 |
| OrgovyxRelugolix | 18 | $45,856 |
| GemtesaVibegron | 26 | $21,249 |
| Methenamine Hippurate | 58 | $3,783 |
| Tamsulosin Hcl | 201 | $2,291 |
| Estradiol | 50 | $2,186 |
| Testosterone Cypionate | 46 | $2,041 |
| Potassium Citrate ErPotassium Citrate | 12 | $1,526 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $1,207 |
| Solifenacin Succinate | 12 | $1,189 |
| Finasteride | 79 | $761 |
| Trimethoprim | 13 | $486 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $417 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 29 | $390 |
| Cefdinir | 20 | $327 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $34 | $67,10544 claims |
| Astellas Pharma US IncMyrbetriq | $434 | $49,66665 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Lady Lake
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.